• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

GE funds startups to make overdose reversal devices more accessible

April 19, 2017 By Sarah Faulkner

General Electric logoGeneral Electric (NYSE:GE) is reportedly funding 2 of the startups that launched out of its opioid hack-a-thon last year, even though only 1 of the companies won.

The company is backing GEM Boxes, the competition’s winner, and We Are Allies with more than $20,000 worth of funding to help curb the opioid epidemic that kills 91 Americans every day.

GE has been working with the 2 groups since February to support them through mentorship and fundraising, according to a report from the Boston Business Journal. 

GEM Boxes won the competition’s $10,000 grand prize with its idea to develop remotely activated boxes containing the opioid overdose reversal drug, Narcan, that passers-by could administer without needing EMS on the scene.

GE told BBJ that it also awarded an undisclosed amount of funding to We Are Allies, a group that carries Narcan in visible cases in the hopes of drawing attention and fighting the stigma that surrounds addiction. The nonprofit was too promising to ignore, GE said.

“We Are Allies was a special case. They were such a stand-out that we actually put them on a separate track from the other hack finalists and funded them with a Foundation grant,” spokeswoman Susan Bishop told the news outlet. “We don’t typically release grant amounts unless they are quite large. Best I can tell you is that it was a bit larger than the $10,000 prize based on the speed to market and early planning and success we saw in the We Are Allies solution.”

The 1st needle-free version of the opioid overdose reversal drug naloxone won FDA approval in January last year. This year, Adapt Pharma said that the FDA approved the 2mg formulation of its Narcan nasal spray for the emergency treatment of opioid overdose.

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Research & Development Tagged With: generalelectric

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS